Difficulty: Medium
Average Score: 90%
Practice
The tetracycline safe in renal failure is
Correct answer
C
Rationale
In this case, the correct answer is C) Enalapril. Tetracyclines are antibiotics commonly used to treat various bacterial infections. When it comes to using tetracyclines in patients with renal failure, it is important to consider the potential for drug accumulation due to decreased renal clearance. Enalapril, an angiotensin-converting enzyme (ACE) inhibitor, is safe to use in renal failure because it is primarily eliminated through the hepatic system and does not rely heavily on renal clearance. This makes it a suitable choice for patients with compromised kidney function.
Now, let's discuss why the other options are incorrect:
A) Digoxin: Digoxin is primarily eliminated through the kidneys, so it can accumulate in patients with renal failure, making it potentially toxic.
B) Furosemide: Furosemide is a loop diuretic that is commonly used in renal failure to help manage fluid overload. However, it does not have a direct impact on the safety of tetracycline use in renal failure.
D) Amrinone: Amrinone is an inotropic agent that is primarily eliminated through the kidneys. Like digoxin, it can accumulate in patients with renal failure, leading to potential toxicity.
Educational context: Understanding the pharmacokinetics and pharmacodynamics of drugs is crucial in clinical practice, especially when managing patients with renal failure. Healthcare professionals need to be aware of which medications are safe to use in this population to prevent adverse drug reactions and ensure optimal patient outcomes. This knowledge helps in making informed decisions when prescribing medications and managing drug therapy in patients with renal impairment.
Now, let's discuss why the other options are incorrect:
A) Digoxin: Digoxin is primarily eliminated through the kidneys, so it can accumulate in patients with renal failure, making it potentially toxic.
B) Furosemide: Furosemide is a loop diuretic that is commonly used in renal failure to help manage fluid overload. However, it does not have a direct impact on the safety of tetracycline use in renal failure.
D) Amrinone: Amrinone is an inotropic agent that is primarily eliminated through the kidneys. Like digoxin, it can accumulate in patients with renal failure, leading to potential toxicity.
Educational context: Understanding the pharmacokinetics and pharmacodynamics of drugs is crucial in clinical practice, especially when managing patients with renal failure. Healthcare professionals need to be aware of which medications are safe to use in this population to prevent adverse drug reactions and ensure optimal patient outcomes. This knowledge helps in making informed decisions when prescribing medications and managing drug therapy in patients with renal impairment.